Gubra A/S

Corporate Details

ISIN(s):

DK0062266474

LEI:

254900T17RRFZONO6W53

Country:

Denmark

Address:

Hørsholm Kongevej 11 B, 2970 Hørsholm

Website:

https://www.gubra.dk/

Sector:

Health Care

Industry:

Biotechnology

Description

Gubra, founded in 2008 in Denmark, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P). The two business areas are highly synergistic and create a unique entity capable of generating a steady cash flow from the CRO business while at the same time enjoying biotechnology upside in the form of development milestone payments and potential royalties from the D&P business.